by Plus Therapeutics | Aug 23, 2024 | Uncategorized
Mark your calendars! Our clinical and patient advocacy teams will be speaking at some upcoming @HeadfortheCure patient and caregiver events. Tune in to learn about Glioblastoma and our ongoing ReSPECT-GBM clinical trial. For more information and to sign up, click...
by Plus Therapeutics | Aug 22, 2024 | Uncategorized
Now Streaming: Replay the live symposium by Plus Therapeutics presented at the 2024 SNO/ASCO CNS Metastases Conference in Denver, CO. Watch on YouTube: https://youtu.be/kOWF7ym0WSE
by Plus Therapeutics | Aug 12, 2024 | LM
Highlights include: > Respect-LM dosing shows continued feasibility and safety of up to 44 mCi of intrathecal Rhenium (186Re) Obisbemeda > High absorbed radiation doses, mean circulating tumor cell reductions, and median overall survival of 12 months continue to...
by Plus Therapeutics | Aug 6, 2024 | Uncategorized
Attending SNO/ASCO CNS Conference in Denver this week? So are we! Read the full details on our upcoming symposium, oral presentations, and posters: https://bit.ly/3LFxFMS...
by Plus Therapeutics | Aug 2, 2024 | Uncategorized
Plus Therapeutics is proud to be a Bronze Supporter and Exhibitor at the SNO / ASCO CNS Conference this year! Come by our booth, posters, and presentations we have going on throughout the conference. Detail including times and presentation titles:...
Recent Comments